A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
Clinical trial NCT00160524 · COMPLETED
Trial details
- NCT number
- NCT00160524
- Sponsor
- UCB Pharma SA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Primary completion
- 2012-08-01
- Enrollment
- 596
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.